Lack of prognostic significance for p53-overexpression and Ki-67- immunoreactivity in oral T1-2 squamous cell carcinomas

Oncology Reports

Volumn 4, Issue 4, 1997, Pages 737-742

  Lange, Dariusz ^a,b   Heyden, Anders ^b   Lie, Erik Stenseth ^b   Brandtzaeg, Per ^b   Boysen, Morten ^b,c   Clausen, Ole Petter Fraas ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Histopathology; Immunohistochemistry; Ki 67; Oral cavity; p53; Prognosis; Squamous cell carcinoma

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER INVASION; CANCER SURVIVAL; GENE EXPRESSION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIAGNOSIS;

EID: 0030816713     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.4.737     Document Type: Article

References (30)

1. Bryne M, Koppang HS, Lilleng R and Kjaerheim A: Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166: 375-381, 1992.
2. Roland NJ, Caslin AW, Nash J and Stell PM: Value of grading squamous cell carcinoma of the head and neck. Head Neck 14: 224-229, 1992.
3. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL and Casey G: Frequent p53 mutations in head and neck cancer. Cancer Res 52: 5997-6000, 1992.
4. Gerdes J, Schwab U, Lemke H and Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20, 1993.
5. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J and Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363, 1992.
6. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, et al: Prognostic significance of p53 mutations and 3p deletions in primary resected non-small lung cancer. Cancer Res 53: 1-4, 1993.
7. Tholacius S, Börresen AL and Eyfjord JE: Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res 53: 1637-1641, 1993.
8. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS and Gluckman JL: The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 119: 1118-1122, 1993.
9. Frank JL, Bur ME, Garb JL, Kay S, Ware JL, Sismanis A and Neifeld JP: p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 73: 181-186, 1994.
10. Nylander K, Stenling R, Gustafsson H, Zackrisson B and Roos G: p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer 75: 87-93, 1995.
11. Roland NJ, Caslin AW, Bowie GL and Jones AS: Has the cellular proliferation marker Ki-67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol 19: 13-18, 1994.
12. Högmo A, Munck-Wikland E, Kuylenstierna R, Lindholm J and Auer G: Nuclear DNA content and p53 immunostaining in oral squamous cell carcinoma - an analysis of a consecutive 10-year material. Int J Oncol 5: 915-920, 1994.
13. Jones AS, Roland NJ, Caslin AW, Cooke TG, Cooke LD and Forster G: A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J Laryngol Otol 108: 859-864, 1994.
14. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
15. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M and Welsh D: The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69: 409-416, 1994.
16. Van den Berg FM, Baas IO, Polak MM and Offerhaus GJ: Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol 142: 381-385, 1993.
17. Girod SC, Pape HD and Krueger GR: p53 and PCNA expression in carcinogenesis of the oropharyngeal mucosa. Eur J Cancer Part B Oral Oncol 30B: 419-423, 1994.
18. Lavieille JP, Brambilla E, Riva-Lavieille C, Reyt E, Charachon R and Brambilla C: Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Oto-Laryngol 115: 334-339, 1995.
19. Langdon JD and Partridge M: Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg 30: 214-220, 1992.
20. Sauter ER, Ridge JA, Trock B, Cleveland D, Whitley KV, Mohr RM and Klein-Szanto A: Overexpression of the p53 gene in primary and metastatic head and neck carcinomas. Laryngoscope 105: 653-656, 1995.
21. Field JK, Malliri A, Butt SA, Gosney JR, Phillips D, Spandidos DA and Jones AS: P53 overexpression in end stage squamous cell carcinoma of the head and neck: correlation with a very poor clinical outcome. Int J Oncol 3: 431-435, 1993.
22. Vojtesek B, Bartek J, Midgley CA and Lane DP: An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151: 237-244, 1992.
23. Pavelic ZP, Portugal LG, Gootee MJ, Stambrook PJ, Smith C, Mugge RE, et al: Retrieval of p53 protein in paraffin-embedded head and neck tumor tissues. Arch Otolaryngol Head Neck Surg 119: 1206-1209, 1993.
24. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM and Sidransky D: The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53: 4477-4480, 1993.
25. Lane DP: Cancer. p53, guardian of the genome. Nature 358: 15-16, 1992.
26. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992.
27. Munakata S and Hendricks JB: Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem 41: 1241-1246, 1993.
28. Xin X, Stenersen TC, Clausen OPF and Boysen M: Nucleolar organizer regions and prognosis in glottic squamous cell carcinoma. Head Neck 19: 20-26, 1997.
29. Welkoborsky H-J, Hinni M, Dienes H-P and Mann WJ: Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 104: 503-510, 1995.
30. Slootweg PJ, Koole R and Hordijk GJ: The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur J Cancer Part B Oral Oncol 30B: 138-141, 1994.